1 drug(s) with this reaction
11,436 total reports
Device Adhesion Issue has been reported as an adverse reaction across 1 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 11,436 adverse event reports mention device adhesion issue in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with device adhesion issue, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have device adhesion issue listed in their FDA adverse event reports, sorted by report count:
In addition to device adhesion issue, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
1 drug(s) manufactured by Amgen Inc have device adhesion issue listed in their FDA adverse event reports: PEGFILGRASTIM.
There are a combined 11,436 reports of device adhesion issue across 1 Amgen Inc drug(s) in the FDA adverse event database.